iBET works in a broad range of fields that encompass multidisciplinary approaches ranging from basic, technological to clinical and translational research, from the development of complex biopharmaceuticals and novel therapies to areas in food and health, including nutraceuticals development and agro-forestry.
Our LinkedIn community has now more than 5000 followers! Thank you for following us and helping us grow
Check out our latest news and accomplishments in the July edition of Facts & Figures
iBET joined EATRIS, an European translational research infrastructure. Within EATRIS, iBET is part of the ATMP and Vaccines platforms
More than 8M€ attributed to H2020 project CRUZIVAX for the development of a vaccine for Chagas disease